A recent case series suggests that the use of quantitative neuromuscular monitoring, when applied prior to the expected recovery of neuromuscular function, can detect BChE deficiency in patients early enough to allow the anesthesiologist to prevent premature emergence from anesthesia in patients with delayed metabolism of neuromuscular drugs [53]. This evidence concerns the gene BCHE and hyperinsulinemic hypoglycemia, familial, 4.